Distinct protective host defenses against oral and vaginal candidiasis.
about
A human-curated annotation of the Candida albicans genome.Host pathogen relations: exploring animal models for fungal pathogensCytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarminsOropharyngeal candidiasis in the era of antiretroviral therapyCharacterization of CD8+ T cells and microenvironment in oral lesions of human immunodeficiency virus-infected persons with oropharyngeal candidiasis.Characterization of the immune status of CD8+ T cells in oral lesions of human immunodeficiency virus-infected persons with oropharyngeal Candidiasis.The emerging world of the fungal microbiome.Mucosal immunity and Candida albicans infection.Candida-host interactions in HIV disease: implications for oropharyngeal candidiasisTranscriptomic analysis of vulvovaginal candidiasis identifies a role for the NLRP3 inflammasome.The prevalence of urogenital infections in pregnant women experiencing preterm and full-term laborImmunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.Protocols for vaginal inoculation and sample collection in the experimental mouse model of Candida vaginitisHuman epithelial cells establish direct antifungal defense through TLR4-mediated signalingThe host cytokine responses and protective immunity in oropharyngeal candidiasis.New advances in fatty acids as antimalarial, antimycobacterial and antifungal agents.Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis.Colonization by Candida species of the oral and vaginal mucosa in HIV-infected and noninfected women.Oral Candida infection and colonization in solid organ transplant recipientsImmune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis.Baofukang suppository promotes the repair of vaginal epithelial cells in response to Candida albicans.An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.Vaginal epithelial cell-derived S100 alarmins induced by Candida albicans via pattern recognition receptor interactions are sufficient but not necessary for the acute neutrophil response during experimental vaginal candidiasis.Vaginal Heparan Sulfate Linked to Neutrophil Dysfunction in the Acute Inflammatory Response Associated with Experimental Vulvovaginal Candidiasis.Interplay between Candida albicans and the mammalian innate host defense.The significance of Candida in the human respiratory tract: our evolving understanding.Central Role for Dermal Fibroblasts in Skin Model Protection against Candida albicans.The vaginal mycobiome: A contemporary perspective on fungi in women's health and diseasesSusceptibility pattern and molecular type of species-specific Candida in oropharyngeal lesions of Indian human immunodeficiency virus-positive patients.CANDIDA ALBICANS AND NON-ALBICANS SPECIES AS ETIOLOGICAL AGENT OF VAGINITIS IN PREGNANT AND NONPREGNANT WOMEN.Innate Immunity to Mucosal Candida Infections.A novel mechanism behind the immunopathogenesis of vulvovaginal candidiasis: "Neutrophil Anergy".Human defects in STAT3 promote oral mucosal fungal and bacterial dysbiosis
P2860
Q21145286-C4257D34-B9D0-4BAB-A431-1D5DCF7646F2Q26862890-09A4AC09-E790-4239-AC1F-21386CC54612Q27021956-1EC112FA-62CA-4515-A8E3-217D45301466Q33746435-293E315D-97AF-49D3-B768-DFDE2C29F0A9Q33788275-85F5329A-5651-4B6D-8FAE-E31CB6752087Q34720260-13B63C95-C007-455A-A0B5-FEB8D0C92BD7Q34727901-266C2EF2-2A35-4EDA-BA4C-D74FC9AFB988Q35109998-67B41875-30EB-4495-9E2A-F2D350A0B490Q35129063-AF0E835E-035D-4A76-9976-54022F616EA1Q35677592-CE9424F2-5775-4F1F-BA2F-3A231BFB5C43Q35810362-DD07E660-2578-4A2F-BF35-3F671A958921Q35920633-932C4123-5503-4EF2-9310-161396445F3AQ36015132-2406AF36-51A7-40A7-82F6-F1035E2ABEB4Q36121769-2DEDE436-70C0-416A-BDBA-E7C0DE63C20DQ36295907-1DB33429-F71B-4CF2-A6BF-03E59C95435DQ36453948-B5728C2A-C697-49C3-B40B-ADC35CC9702BQ36467675-E89251C8-5ADD-4359-8C94-2AA4D130EF6AQ36509561-D9D81989-D555-4286-A425-047F80DCEA93Q37235612-9FCCFCDA-07B1-4F41-A4FD-4D73819C8F86Q37267375-03EA7B7A-3C9F-4681-92AC-6546F1E7791AQ37405227-AC9F68E1-0AD5-4CA8-96EE-A88BFCCCF846Q37427108-1D063CB3-4ACE-42E8-901C-23103619C0A2Q37546318-D3FC0727-F88C-4309-914D-50CB7D5315B9Q37700062-6700D34F-7A22-4B55-9257-C64FA405D383Q37976620-BEE2ED33-C1A0-4E6B-8183-97075CE147DCQ39250702-5CD1F9D4-673F-4167-83F6-16F74794B043Q40268085-CC49CD62-258B-4AD8-AADB-842A70E7B763Q40531004-1439F28A-E8EA-4CAB-8F72-27B1838DCB0CQ40638386-07078BCB-551B-4246-9B81-D80BA4505C46Q47110327-158C6E59-78C0-42D1-98FE-1DB8497485E1Q48163042-A537CCC7-C217-4B16-9689-9A47E4B8BA61Q50083006-4F655C76-14E2-4B27-8C72-9C00C746B300Q58760701-D56E03DB-A20B-474E-8578-D054761CCC56
P2860
Distinct protective host defenses against oral and vaginal candidiasis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Distinct protective host defenses against oral and vaginal candidiasis.
@ast
Distinct protective host defenses against oral and vaginal candidiasis.
@en
Distinct protective host defenses against oral and vaginal candidiasis.
@nl
type
label
Distinct protective host defenses against oral and vaginal candidiasis.
@ast
Distinct protective host defenses against oral and vaginal candidiasis.
@en
Distinct protective host defenses against oral and vaginal candidiasis.
@nl
prefLabel
Distinct protective host defenses against oral and vaginal candidiasis.
@ast
Distinct protective host defenses against oral and vaginal candidiasis.
@en
Distinct protective host defenses against oral and vaginal candidiasis.
@nl
P2860
P356
P1433
P1476
Distinct protective host defenses against oral and vaginal candidiasis.
@en
P2093
Paul L Fidel
P2860
P304
P356
10.1080/MMY.40.4.359.375
P577
2002-08-01T00:00:00Z